The ABN AMRO Break-up, 2007Medium

In short

A bank bought in cash by a consortium at the top of a cycle, with the pieces divided in advance — and the capital paid out just before it was needed.

3 min read · 516 words · Updated

What happened

  • March 2007 — a Dutch bank is in discussions with a UK bank about an agreed combination in shares.
  • April 2007 — a consortium of three European banks assembles a competing offer, mostly in cash, and higher. Each member is to take specified parts of the target.
  • October 2007 — the consortium offer prevails and completes, as the largest banking transaction of its time, paid overwhelmingly in cash.
  • Within a year — the wholesale funding markets tighten severely; one consortium member reports very large losses and receives a UK government recapitalisation in October 2008.
  • The Dutch parts are taken into state ownership by the Netherlands in October 2008.

The mechanism

  • Cash consideration takes the buyer's shareholders out of the decision. In a share deal they vote on issuing the currency; in a cash deal of this shape they frequently do not, and the balance-sheet effect lands on them anyway.
  • A consortium bid is several acquisitions in one offer. The separation of the target is agreed before completion, which raises the price a seller can achieve and multiplies the execution risk after it.
  • The price was paid in capital. Cash for a bank acquisition is regulatory capital leaving the buyer's balance sheet at the moment it is committed, not when the accounts are prepared.
  • Due diligence on the target was limited in the contested phase, which is a structural feature of a hostile or competitive situation rather than an oversight — see what kills a deal on the diligence blocker.
  • Nothing here required the transaction to be wrong to be dangerous. The same purchase funded in shares would have left a different capital position facing the same year.

What it teaches

  • Ask what the consideration does to the buyer's balance sheet, not only what it does to earnings per share. A deal can be accretive and still leave the acquirer thinner.
  • Competitive tension raises the price and lowers the information. Both move together, and a seller running a process is buying the first with the second.
  • A consortium multiplies the post-completion risk: three integrations, three sets of assumptions, one signature.
  • Timing is a risk nobody underwrites. The cycle is not a diligence item, and a transaction agreed in one funding environment completes in whichever one arrives.

The mechanisms behind this

Every case on this site is an instrument or a mechanism doing exactly what it was built to do, in a situation nobody had pictured. These are the pages that explain the machinery:

Information and education only. This is a simplified summary of publicly reported events, written for teaching purposes. It compresses a complex episode, omits material detail, and does not characterise the conduct or motives of any person or organisation. It is not advice, not a forecast, and not a recommendation about any market, instrument or institution.

Information and education only. Every page, figure and calculator on this site exists to explain how financial instruments work. Nothing here is investment, tax or legal advice, a recommendation, or a valuation you can rely on. Full disclaimer